{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:36:30Z","timestamp":1783488990995,"version":"3.55.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["3574"],"award-info":[{"award-number":["3574"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","award":["71004"],"award-info":[{"award-number":["71004"]}],"id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116204","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T03:37:53Z","timestamp":1632109073000},"page":"116204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Hypophosphatasia: Vitamin B6 status of affected children and adults"],"prefix":"10.1016","volume":"154","author":[{"given":"Michael P.","family":"Whyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Wenkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinieth N.","family":"Bijanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Ericson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116204_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2021.116204_bb0010","series-title":"Hypophosphatasia: Nature\u2019s Window on Alkaline Phosphatase Function in Humans, Chapter 66 in \u201cPrinciples of Bone Biology\u201d","first-page":"1525","author":"Whyte","year":"2020"},{"key":"10.1016\/j.bone.2021.116204_bb0015","series-title":"Genetics of Bone Biology and Skeletal Disease","first-page":"481","article-title":"Hypophosphatasia and how alkaline phosphatase promotes mineralization. Chapter 28","author":"Whyte","year":"2018"},{"key":"10.1016\/j.bone.2021.116204_bb0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"Suppl. II","key":"10.1016\/j.bone.2021.116204_bb0025","first-page":"1","article-title":"Phosphorylethanolamine and hypophosphatasia","volume":"15","author":"Rasmussen","year":"1968","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.bone.2021.116204_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0002-9343(78)90189-4","article-title":"The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia","volume":"64","author":"Licata","year":"1978","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2021.116204_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3276003","article-title":"Structural and functional roles of glycosylphosphatidy-linositol in membranes","volume":"239","author":"Low","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bone.2021.116204_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","volume":"2","author":"Russell","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2021.116204_bb0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI106589","article-title":"Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone","volume":"50","author":"Russell","year":"1971","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2021.116204_bb0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.bone.2021.116204_bb0055","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\u2032-phosphate levels in hypophosphatasia: alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2021.116204_bb0060","first-page":"4485","article-title":"Scientific opinion on dietary reference values for vitamin B6","volume":"14","author":"EFSA NDA Panel","year":"2016","journal-title":"EFSA J."},{"key":"10.1016\/j.bone.2021.116204_bb0065","series-title":"Endocrine Control of Bone and Calcium Metabolism","first-page":"93","article-title":"The relationship between phosphoethanolamine level in serum and intractable seizure on hypophosphatasia infantile form","volume":"vol. 8-B","author":"Takahashi","year":"1984"},{"key":"10.1016\/j.bone.2021.116204_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0075","first-page":"453","article-title":"Premature exfoliation of teeth in childhood and adolescence","volume":"41","author":"Hartsfield","year":"1994","journal-title":"Adv. Pediatr. Infect. Dis."},{"key":"10.1016\/j.bone.2021.116204_bb0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/154405910508401110","article-title":"Cementum and dentin in hypophosphatasia","volume":"84","author":"Van den Bos","year":"2005","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0085","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116204_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2021.116204_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85971","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2021.116204_bb0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","article-title":"Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters","volume":"29","author":"Gua\u00f1abens","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2019.01.049","article-title":"Natural history of perinatal and infantile hypophosphatasia: a retrospective study","volume":"209","author":"Whyte","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2021.116204_bb0115","series-title":"Current Topics in Nutrition and Disease Volume 19: Clinical and Physiological Application of Vitamin B-6","first-page":"65","article-title":"Role of phosphatases in the regulation of vitamin B-6 metabolism in hypophosphatasia and other disorders","author":"Coburn","year":"1988"},{"key":"10.1016\/j.bone.2021.116204_bb0120","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4274\/jcrpe.473","article-title":"Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report","volume":"4","author":"Demirbilek","year":"2012","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.bone.2021.116204_bb0130","series-title":"Tissue Nonspecific Alkaline Phosphatase Gene Mutations Database Yvelines (France)","author":"Mornet","year":"2020"},{"key":"10.1016\/j.bone.2021.116204_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: an overview for 2017","volume":"102","author":"Whyte","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2018.01.022","article-title":"Hypophosphatasia: biochemical hallmarks validate the expanded pediatric clinical nosology","volume":"110","author":"Whyte","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","article-title":"Hypophosphatasia: enzyme replacement therapy bring new opportunities and new challenges","volume":"32","author":"Whyte","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cercor\/bhh021","article-title":"Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission","volume":"14","author":"Fonta","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bone.2021.116204_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cne.20524","article-title":"Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex","volume":"486","author":"Fonta","year":"2005","journal-title":"J. Comp. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2021.116204_bb0160","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s10545-009-9012-y","article-title":"Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal 5\u2032-phosphate availability","volume":"33","author":"Balasubramaniam","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2021.116204_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1139\/cjpp-2013-0404","article-title":"Pyridoxal-5\u2032-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptors","volume":"92","author":"Theriault","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bone.2021.116204_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0028-3908(01)00110-1","article-title":"Seizures induced by intracerebral administration of phyridoxal 5\u2032-phosphate: effect of GABAergic drugs and glutamate receptor antagonists","volume":"41","author":"Salazar","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bone.2021.116204_bb0175","series-title":"Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP). Subcellular Biochemistry","first-page":"309","article-title":"Neurological symptoms of hypophosphatasia. Chapter 14","volume":"vol. 76","author":"Taketani","year":"2015"},{"key":"10.1016\/j.bone.2021.116204_bb0180","author":"Miller"},{"key":"10.1016\/j.bone.2021.116204_bb0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0003-2697(83)90555-9","article-title":"A versatile cation-exchange procedure of measuring the seven major forms of vitamin B6 in biological samples","volume":"129","author":"Coburn","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bone.2021.116204_bb0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jchromb.2005.07.017","article-title":"Use of chlorite to improve HPLC detection of pyridoxal 5\u2032-phosphate","volume":"823","author":"Ericson","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.bone.2021.116204_bb0195","first-page":"409","article-title":"A micromethod for determination of plasma pyridoxal phosphate and its assessment of storage stability of the vitamer","volume":"6","author":"Borschel","year":"1987","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/00365513.2013.803234","article-title":"Vitamin B6 in plasma - sample stability and the reference limits","volume":"73","author":"Panton","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bone.2021.116204_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","article-title":"Hypophosphatasia: natural history study of 101 affected children studied at a single research center","volume":"93","author":"Whyte","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0210","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/jbmr.130","article-title":"Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Sch\u0151nberg disease (chloride channel 7 deficiency osteopetrosis) among the sclerosing bone disorders","volume":"25","author":"Whyte","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0215","series-title":"Proceedings of the Third International Conference on Vitamin B-6","article-title":"Respnse to L-tryptophan challenge is normal in childhood hypophosphatasia despite markedly increased circulating levels of pyridoxal-5\u2032-phosphate (evidence that alkaline phosphatase acts as an ectoenzyme) (abstract)","author":"Whyte","year":"1987"},{"key":"10.1016\/j.bone.2021.116204_bb0220","series-title":"Methods in Vitamin B-6 Nutrition","first-page":"321","article-title":"The tryptophan load test as an index of vitamin B-6 nutrition","author":"Brown","year":"1981"},{"key":"10.1016\/j.bone.2021.116204_bb0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1969.tb46371.x","article-title":"The tryptophan load as a test for pyridoxine deficiency in hospitalized patients","volume":"166","author":"Coon","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2021.116204_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","article-title":"Adult hypophosphatasia: clinical, laboratory and genetic investigation of a large kindred with review of the literature","volume":"58","author":"Whyte","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bone.2021.116204_bb0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archinte.1981.00340060035010","article-title":"Heterogeneity of adult hypophosphatasia: report of severe and mild cases","volume":"141","author":"Weinstein","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2021.116204_bb0240","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1210\/jc.2013-1811","article-title":"Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure","volume":"98","author":"Whyte","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116204_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116007","article-title":"Vitamin B6 deficiency with normal plasma levels of pyridoxal 5\u2032-phosphate in perinatal hypophosphatasia","volume":"150","author":"Whyte","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0250","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/gut.21.3.192","article-title":"Hydrolysis of pyridoxal-5\u2032-phosphate in plasma in conditions with raised alkaline phosphatase","volume":"21","author":"Anderson","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.bone.2021.116204_bb0255","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/advances\/nmab033","article-title":"Vitamin B-6-induced neuropathy: exploring the mechanisms of pyridoxine toxicity","volume":"12","author":"Hadtstein","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0260","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40264-018-0664-0","article-title":"Vitamin B6 in health supplements and neuropathy: case series assessment of spontaneously reported cases","volume":"41","author":"van Hunsel","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.bone.2021.116204_bb0265","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tiv.2017.07.009","article-title":"The vitamin B6 paradox: supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function","volume":"44","author":"Vrolijk","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bone.2021.116204_bb0270","first-page":"92","article-title":"Hypophosphatasia: pyridoxa1 5\u2032-phosphate levels are markedly increased in hypophosphatasemic plasma but normal in alkaline phosphatase\u2013deficient fibroblasts (evidence for an ectoenzyme role for alkaline phosphatase in vitamin B6 metabolism) (abstract)","volume":"1","author":"Whyte","year":"1986","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0275","article-title":"Neonatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite marked elevations in circulating pyridoxa1\u20135\u2032\u2013phosphate levels","volume":"A\u201387","author":"Whyte","year":"1986","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2021.116204_bb0280","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI113440","article-title":"Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxa1\u20135\/\u2013phosphate (evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase)","volume":"81","author":"Whyte","year":"1988","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bone.2021.116204_bb0285","first-page":"S16","article-title":"Hypophosphatasia skin fibroblasts in culture: a model for exploring bone alkaline phosphatase physiology (abstract)","volume":"34","author":"Whyte","year":"1982","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2021.116204_bb0290","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/jcem-57-4-831","article-title":"Alkaline phosphatase deficiency in cultured skin fibroblasts from patients with hypophosphatasia: comparison of the infantile, childhood, and adult forms","volume":"57","author":"Whyte","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2021.116204_bb0295","first-page":"60A","article-title":"Alkaline phosphatase: identity with pyridoxa1\u20135\/\u2212phosphate phosphatase demonstrated with normal and hypophosphatasia fibroblasts in culture","volume":"1","author":"Fedde","year":"1986","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116204_bb0300","series-title":"Bone and Mineral Research\/6","first-page":"175","article-title":"Alkaline phosphatase: physiological role explored in hypophosphatasia","author":"Whyte","year":"1989"},{"key":"10.1016\/j.bone.2021.116204_bb0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1471-2105-10-273","article-title":"The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families","volume":"10","author":"Percudani","year":"2009","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.bone.2021.116204_bb0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.1711170302","article-title":"Bone growth changes in pyridoxine-deficient rats","volume":"117","author":"Rodda","year":"1975","journal-title":"J. Pathol."},{"key":"10.1016\/j.bone.2021.116204_bb0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/8756-3282(86)90008-6","article-title":"Abnormalities in fracture healing induced by vitamin B6-deficiency in rats","volume":"7","author":"Dodds","year":"1986","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116204_bb0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/8756-3282(96)00072-5","article-title":"Pyridoxine deficiency affects biomechanical properties of chick tibial bone","volume":"18","author":"Masse","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0325","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bone.2007.08.021","article-title":"Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: the Rotterdam study","volume":"41","author":"Yazdanpanah","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0330","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1210\/jc.2007-2710","article-title":"Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women","volume":"93","author":"McLean","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116204_bb0335","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11914-015-0273-0","article-title":"The role of B-vitamins in bone health and disease in older adults","volume":"13","author":"Bailey","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2021.116204_bb0340","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3390\/nu7053322","article-title":"B-vitamins and bone health\u2014a review of the current evidence","volume":"7","author":"Dai","year":"2015","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.bone.2021.116204_bb0345","first-page":"95","article-title":"Tissue-nonspecific alkaline phosphatase regulates purinergic transmission in the central nervous system during development and disease","volume":"15","author":"Sebasti\u00e1n-Serrano","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bone.2021.116204_bb0350","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddw248","article-title":"Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation","volume":"25","author":"Sebasti\u00e1n-Serrano","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2021.116204_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0995-45","article-title":"Mice lacking tissue non-specific alkaline phosphatase die from seizures associated with defective metabolism of vitamin B-6","volume":"11","author":"Waymire","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2021.116204_bb0360","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","article-title":"Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia","volume":"208","author":"Narisawa","year":"1997","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bone.2021.116204_bb0365","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.13950","article-title":"Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis","volume":"140","author":"Cruz","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bone.2021.116204_bb0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/genes10010008","article-title":"The alkaline phosphatase (ALPL) locus is associated with B6 vitamer levels in csf and plasma","volume":"10","author":"Loohuis","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bone.2021.116204_bb0375","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","article-title":"Neurological symptoms in Hypophosphatasia","volume":"30","author":"Colazo","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.bone.2021.116204_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fpsyt.2019.00116","article-title":"Intellectual disability associated with pyridoxine-responsive epilepsies: the need to protect cognitive development","volume":"8","author":"Hassel","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bone.2021.116204_bb0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2020.08.020","article-title":"Pyridoxal in the cerebrospinal fluid may be a better indicator of vitamin B6-dependent epilepsy than pyridoxal 5\u2032-phosphate","volume":"113","author":"Akiyama","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bone.2021.116204_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120972","article-title":"Vitamin B6 in plasma and cerebrospinal fluid of children","volume":"10","author":"Albersen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.116204_bb0395","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2017.07.032","article-title":"Pyridoxal 5\u2032-phosphate, pyridoxal, and 4-pyridoxic acid in the paired serum and cerebrospinal fluid of children","volume":"472","author":"Akiyama","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bone.2021.116204_bb0400","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2018.07.006","article-title":"Pyridoxal 5\u2032-phosphate and related metabolites in hypophosphatasiai: effects of enzyme replacement therapy","volume":"125","author":"Akiyama","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2021.116204_bb0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01800216","article-title":"Increased plasma pyridoxa1\u20135\/\u2013phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia","volume":"13","author":"Chodirker","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2021.116204_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115577","article-title":"Establishing race-, gender- and age-specific reference intervals for pyridoxal 5\u2032-phosphate in the NHANES population to better identify adult hypophosphatasia","volume":"141","author":"Schini","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116204_bb0415","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/ajcn\/53.5.1266","article-title":"Electroencephalographic changes and periodontal status during short-term vitamin-B-6 depletion of young, nonpregnant women","volume":"53","author":"Kretsch","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0420","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ajcn\/53.6.1436","article-title":"Response of vitamin-B-6 content of muscle to changes in vitamin B-6 intake in men","volume":"53","author":"Coburn","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0425","series-title":"Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B-6, Folate, Vitamin B-12, Pantothenic Acid, Biotin, and Choline","author":"Food and Nutrition Board IOM","year":"1998"},{"key":"10.1016\/j.bone.2021.116204_bb0430","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5\u2032-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003\u20132004","volume":"87","author":"Morris","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0435","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ajcn\/38.3.352","article-title":"Effect of megavitamin treatment on mental performance and plasma vitamin B-6 concentrations in mentally retarded young adults","volume":"38","author":"Coburn","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2021.116204_bb0440","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0955-2863(91)90115-L","article-title":"Identification of 5-pyridoxic acid and 5-pyridoxic acid lactone as metabolites of vitamin B-6 in humans","volume":"2","author":"Mahuren","year":"1991","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bone.2021.116204_bb0445","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10545-012-9493-y","article-title":"Measurement of plasma B-6 vitamer profiles in children with inborn errors of vitamin B-6 metabolism using an LC-MS\/MS method","volume":"36","author":"Footitt","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2021.116204_bb0450","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3177\/jnsv.24.255","article-title":"Effect of pyridoxal administration on the contents of pyridoxal phosphate and \u00ce3-aminobutyric acid in mouse brain","volume":"24","author":"Eto","year":"1978","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.bone.2021.116204_bb0455","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/ajmg.a.61815","article-title":"A cautionary tale of pyridoxine toxicity in cystathionine beta-synthase deficiency detected by two-tier newborn screening highlights the need for clear pyridoxine dosing guidelines","volume":"182","author":"Ames","year":"2020","journal-title":"Am. J. Med. Genet. A"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:45:49Z","timestamp":1762659949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":91,"alternative-id":["S8756328221003707"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116204","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypophosphatasia: Vitamin B6 status of affected children and adults","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116204"}}